Human pathogen group A streptococcus (GAS) has developed mechanisms to subvert innate immunity. We recently reported that the secreted esterase produced by serotype M1 GAS (SsE M1 ) reduces neutrophil recruitment by targeting platelet-activating factor (PAF M28 in a covS deletion mutant of GAS increased neutrophil recruitment and reduced skin infection, whereas in trans expression of SsE M28 in GAS reduced neutrophil infiltration and increased skin invasion in subcutaneous infection of mice. These results suggest that the SsE proteins evolved to target PAF for enhancing innate immune evasion and skin invasion.
M28
possesses much lower esterase activities against triglycerides and other esters than SsE M1 but have similar potency with SsE M1 in PAF hydrolysis. Deletion of sse M28 in a covS deletion mutant of GAS increased neutrophil recruitment and reduced skin infection, whereas in trans expression of SsE M28 in GAS reduced neutrophil infiltration and increased skin invasion in subcutaneous infection of mice. These results suggest that the SsE proteins evolved to target PAF for enhancing innate immune evasion and skin invasion.
A s a strict human pathogen, group A streptococcus (GAS) causes a broad spectrum of illness ranging from relatively mild pharyngitis to severe infections, such as necrotizing fasciitis and streptococcal toxic shock syndrome (1) . The global burden of GAS diseases causes more than 700 million cases of mild, noninvasive infections each year, and at least 517,000 deaths each year due to severe infections (2) . The capacity of GAS to cause infections partly depends on its evasion of neutrophil responses. This innate immune evasion is achieved by the combination of different mechanisms through the action of extracellular virulent factors, including the surface protein M protein, the hyaluronic acid capsule, IL-8/CXC chemokine peptidase SpyCEP, C5a peptidase ScpA, the secreted esterase (SsE), streptolysins S (SLS) and O (SLO), and secreted Mac/IdeS protein. ScpA, SpyCEP, and SsE reduce neutrophil ingress into infection sites (3) (4) (5) (6) (7) (8) . The M protein and hyaluronic acid capsule confer GAS resistance to phagocytosis by neutrophils (9, 10) . Mac/IdeS inhibits opsonophagocytosis by interfering IgG-Fc␥ receptor interaction (11, 12) . In addition, SLS and SLO cause necrosis and apoptosis of neutrophils (13, 14) . Most of these virulence factors are negatively regulated by the two-component regulatory system covRS (also known as csrRS) (15, 16) , and the release of the covRS suppression of the virulence factors critically contributes to the severe evasion of neutrophil responses by and hypervirulence of GAS with naturally selected covS-null mutations or deletion (17) .
Our laboratory has been studying the molecular mechanisms of GAS evasion of innate immunity. We recently found that SsE plays a critical role in GAS inhibition of neutrophil recruitment and functions in part by hydrolyzing platelet-activating factor (PAF) (8, 17) . PAF is a potent lipid mediator and is involved in platelet aggregation, inflammation, neutrophil activation, and allergic response (18) (19) (20) (21) (22) . In addition, PAF has been implicated as a chemoattractant in recruitment of eosinophils, neutrophils, and monocytes (22) . The potent biological functions of PAF are regulated by PAF-acetylhydrolases (PAF-AHs) (23) (24) (25) (26) , which inactivate PAF by removing the acetyl ester group at the sn-2 position of PAF. Known mammal PAF-AHs include the secreted or plasma, intracellular type I, and intracellular type II PAF-AHs (23) (24) (25) (26) . These PAF-AHs belong to different phospholipase A 2 groups (27) . Group VII includes the plasma and intracellular type II PAF-AHs, and group VIII has the type I PAF-AHs. Although the type I PAFAHs are specific for PAF, the plasma and type II PAF-AHs have broader substrate specificity (28) .
PAF-AH activity has been also detected in bacteria and fungi. An intracellular yeast group VII PAF-AH enhances the viability of yeast under oxidative stress (29) . The spirochete Leptospira interrogans produces a PAF-AH (30) . An apparently intracellular esterase Est13 from an earthworm gut-associated microorganism inhibits PAF-induced platelet aggregation (31) . Both L. interrogans PAF-AH and Est13 share sequence homology with the ␣1 subunit of the type I intracellular mammalian PAF-AH. The function of these bacterial PAF-AHs is not known. In contrast to these yeast and bacterial PAF-AHs, PAF-AH produced by serotype M1 GAS (SsE M1 ) is a secreted protein (32) . This SsE M1 protein is a protective antigen and virulence factor and contributes to innate immune evasion partly by hydrolyzing PAF (8, 32, 33) . There are two SsE variant complexes among GAS isolates. Complex I includes the SsE proteins that are produced by serotypes M1, M2, M3, M5, M6, M12, and M18 GAS, and complex II has the SsE proteins that are produced by M4, M28, and M49. The SsE proteins within each complex share Ͼ98% identity in amino acid sequence but have ca. 37% sequence variation between the complexes (32). It is not known whether SsE within complex II also has PAF-AH activity and is involved in innate immune evasion. The enzymatic parameters and substrate specificity of SsE M1 have not been determined. To address this question, we prepared SsE of serotype M28 GAS (SsE M28 ) and characterized its esterase and PAF-AH activities in comparison with SsE M1 and human plasma PAF-AH (hpPAF-AH) and its contribution to GAS inhibition of neutrophil recruitment. We found that SsE M28 is a potent PAF-AH and has much lower esterase activities against tested esters than SsE M1 and that SsE M28 contributes to GAS inhibition of neutrophil recruitment and skin invasion.
MATERIALS AND METHODS

Materials.
Vinyl propionate, vinyl butyrate, triacetylglycerol, tripropionylglycerol, tributyroylglycerol, trioctanoylglycerol, and diisopropyl fluorophosphate (DFP) were purchased from Sigma (St. Louis, MO). Vinyl acetate was purchased from Fisher Scientific (Fair Lawn, NJ). PAF C-16 (1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine), lyso-PAF C-16 (1-O-hexadecyl-sn-glycero-3-phosphocholine), recombinant hpPAF-AH, and 2-thio-PAF were purchased from Cayman Chemical (Ann Arbor, MI). [Acetyl-
3 H]PAF with a specific radioactivity of 27 Ci/mmol was purchased from Perkin-Elmer, Inc. (Boston, MA).
Gene cloning and SsE M28 expression and purification. The fragment of the sse M28 gene encoding the mature SsE M28 (amino acid residues 27 to 333) was PCR amplified from serotype M28 GAS strain BAA1064 (also called MGAS6180), which was obtained from ATCC, using the primers 5=-ACCATGGATGCCAGTTCTAGATCTTG-3= and 5=-AGAATTCTTA GTAAGCTTTTTGAATCG-3=. The underlined sequences were added to introduce NcoI and EcoRI restriction sites, respectively. The PCR product obtained was cloned into pET-His2 (34) at the NcoI and EcoRI sites. Recombinant SsE M28 was expressed and purified from E. coli strain BL21(DE3) that contained the cloned sse M28 gene. The bacteria were grown in 6 liters of Luria-Bertani broth supplemented with 100 mg of ampicillin/liter at 37°C. When the optical density at 600 nm (OD 600 ) of the culture was ϳ0.5, the final concentration of 0.5 mM IPTG (isopropyl-␤-D-thiogalactopyranoside) was added to induce SsE M28 production. After 10 h of induction, bacteria were harvested by centrifugation. The bacterial pellet obtained was suspended in 80 ml of 20 mM Tris-HCl (pH 8.0), sonicated on ice for 20 min, and centrifuged. The lysate was adjusted to 0.5 M NaCl and loaded on a Ni-nitrilotriacetic acid agarose column (2.5 by 3 cm). The column was washed with 50 ml of 20 mM Tris-HCl containing 0.5 M NaCl and eluted with 70-ml gradient of 0 to 100 mM imidazole. Fractions containing SsE M28 were pooled and dialyzed against 3 liters of 20 mM Tris-HCl, and the dialyzed sample was loaded onto a DEAESepharose column (1.5 by 7 cm). The column was washed with 20 ml of 20 mM Tris-HCl and eluted with a 90-ml gradient of 0 to 200 mM NaCl, and fractions containing SsE M28 with 95% purity were pooled, dialyzed against 20 mM Tris-HCl, and concentrated using GE Healthcare Vivaspin 20 filtration devices.
Recombinant SsE protein of serotype M1 GAS (SsE  M1 ) and SeE, the homologue of SsE in Streptococcus equi, were prepared as previously described (32, 35) . Protein concentrations were determined using the modified Lowry protein assay kit from Pierce with bovine serum albumin as a standard.
Assays for PAF-AH activity. SsE-catalyzed hydrolysis of PAF was monitored by thin-layer chromatography (TLC), a colorimetric assay using 2-thio-PAF (8) , and the standard assay using [acetyl-3 H]PAF (36) . In the TLC assay, PAF (0.29 mM) was mixed with 7 M SsE M28 in 20 l of 20 mM Tris-HCl (pH 8.0) or the buffer (negative control reaction), and the reactions were stopped by adding 20 l of acetonitrile containing 1% formic acid after 20 min incubation at room temperature. Then, 4 l of the reaction samples, lyso-PAF, and PAF/lyso-PAF mixtures were spotted on a Whatman K6F Silica Gel 60Å TLC plate, and these compounds were resolved using a chloroform-methanol-water (65:35:7 by volume) solution as the mobile phase. After chromatography, PAF and lyso-PAF were visualized by spraying with 5% ammonium molybdate sulfate and heating.
In the colorimetric assay, the reactions were initiated by mixing 100 l of 20 mM Tris-HCl (pH 8.0), containing 2-thio PAF at various concentrations and 100 l of 20 mM Tris-HCl containing 2.1 nM SsE M28 and 0.5 mM 5,5=-dithiobis-(2-nitrobenzoic acid) (DTNB) at room temperature in a 96-well plate. The absorbance at 414 nm of the reactions was recorded every 9 s using a SPECTRA Max 384 Plus spectrophotometer (Molecular Devices, Sunnyvale, CA), and the time course of ⌬A 414 was used to determine initial rates of hydrolysis of 2-thio PAF. For detecting PAF-AH activity in the supernatant of GAS cultures, 100 l of culture supernatant from the mid-exponential growth phase (OD 600 ϭ 0.35) was mixed with 40 l of a solution containing 0.88 mM 2-thio PAF and 1.26 mM DTNB.
The standard assay was performed as described previously (36) . Briefly, 0.1 mM PAF solution was prepared by mixing 42 l of unlabeled PAF and 50 l of [acetyl-
3 H]PAF in 4 ml of phosphate-buffered saline (PBS; pH 7.2). In this solution, the final molar ratio of unlabeled and labeled PAF was determined to be 2,547:1. Then, 10 l of testing protein in PBS (pH 7.2) was mixed with 40 l of PAF at various concentrations and incubated at 37°C for 30 min. After incubation, 50 l of 0.1 M acetic acid was added into the mixture, immediately followed by adding 1.5 ml of 0.1 M sodium acetate solution. The whole reaction mixture was then loaded onto a preconditioned octadecyl silica gel cartridge (catalog no. JTB 7020-03 from J.T. Baker), and the filtrate containing [ 3 H]acetate was collected. After mixed with 4 ml of ScintiVerse BD LSC Cocktail (Fisher Scientific, Pittsburg, PA), [ 3 H]radioactivity in the filtrate was determined using a Beckman LS 6500 Scintillation Counter. Mole numbers of hydrolyzed PAF were determined by measuring the [ 3 H]acetate radioactivity in each reaction filtrate, which was calculated based on a standard curve and the specific radioactivity of the PAF solution.
Assay for esterase activity. The esterase activity of SsE was determined with potentiometric titration using a pH-stat (model 360; Denver Instruments, USA), as described previously (35) . SsE was stirred together with each substrate at the specified concentrations at 25°C in 25 ml of 2.0 mM Tris-HCl (pH 7.6), and the released acid was titrated in real time with 0.02 M NaOH to keep pH at 7.6 for 3 min. Hydrolysis rate was measured from the slope of the plot of the volume of NaOH added versus time.
Inactivation of SsE M1 and SsE M28 by DFP. SsE M1 (0.4 mg/ml) or SsE M28 (1.2 mg/ml) in 100 l of 20 mM Tris-HCl (pH 7.4) was incubated with DFP, a serine esterase-specific inhibitor (37), at concentrations from 0 to 100 M at 37°C for 30 min, and the remaining activity of the treated enzyme was determined by using 100 mM vinyl propionate as described above in the assay for esterase activity.
Generation of MGAS6180 mutants. An sse M28 fragment encoding amino acids 63 to 255 of MGAS6180 was deleted using pGRV⌬sse M28 as previously described (17) , yielding ⌬sse MGAS6180 . pGRV⌬sse M28 was constructed as follows. The 3= and 5= flanking fragments of the target fragment were amplified from the MGAS6180 chromosomal DNA using two pairs of primers 5=-GGATCCTTGATAAGTAACCGTGAGCTT-3= (primer 1)/5=-CCCATCGATTCAACTTCAACAGTTGACATATTGATC AAACTTAG-3= (primer 2) and 5=-TGTTGAAGTTGAATCGATGGGGG AGATGTATCAGGGCTAG-3= (primer 3)/5=-GGATCCTAAAGAAGTC GGTAATGCTCA-3= (primer 4), respectively. The two PCR fragments were fused together by subsequent overlay PCR via the underlined 21-bp complementary tag sequences in primers 2 and 3 using the primers 1 and 4. The fused PCR product was subcloned into pGRV (38) at the BamHI site.
A covS gene fragment encoding amino acids 39 to 468 of CovS in MGAS6180 and ⌬sse MGAS6180 was deleted using pGRV⌬covS M28 as described previously (17) , yielding ⌬covS and ⌬sse⌬covS. pGRV⌬covS M28 was constructed as follows. The 3= and 5= ϳ1,000-bp flanking fragments of the covS fragment were amplified from the MGAS6180 chromosomal DNA using the pairs of primers 5=-GGGGACAAGTTTGTACAAAAAAG CAGGCTTGAAATAGTCTAGGATATGAG-3= (primer 5)/5=-ATGTCT TGACATCAGTAGCAAGGCAATCAGTGTAAAGGCAGA-3= (primer 6) and 5=-TTGCTACTGATGTCAAGACATGTAGATGGGTATCATTT ACAG-3= (primer 7)/5=-GGGGACCACTTTGTACAAGAAAGCTGGGT AGTCACCGAATCAAGAGTTA-3= (primer 8), respectively. The two PCR fragments were fused together by subsequent overlay PCR via the 21-bp complementary tag sequences that are underlined in primers 6 and 7 using the primers 5 and 8. The fused PCR product was first cloned into the donor vector pDONR221 in the BP reaction and then into pGRV-RFA in the LR reaction using the Gateway Cloning Technology. pGRV-RFA was modified from pGRV by cloning the reading frame cassette A of the Gateway Cloning system at the SmaI site.
Quantitative RT-PCR analysis. GAS strains were grown in THY to an OD 600 of 0.3. GAS bacteria were harvested by centrifugation and incubated at room temperature for 5 min after the addition of 2 volumes of RNAprotect (Qiagen, Valencia, CA) to ensure RNA integrity. Total RNA was isolated using RNeasy minikit (Qiagen). RNA preparations were verified to be free of DNA by PCR. The relative levels of specific gene transcripts were measured by one-step SYBR quantitative reverse transcription-PCR (RT-PCR) assay. Changes in the levels of gene expression were compared using the ⌬⌬C T method with normalization to the control gene gyrA. All RNA samples were assayed in triplicate, and the data represent mean values Ϯ the standard deviations (SD).
In trans overexpression of SsE M28 . The sse M28 gene of MGAS6180 was PCR cloned into pDCBB-FRA with the Gateway Technology according to the manufacturer's manual. pDCBB (39) was modified into pDCBB-RFA by inserting the blunt-ended reading frame cassette A into pDCBB at the EcoRV site. The sse M28 gene was PCR amplified using Phusion DNA polymerase (New England BioLabs, Ipswich, MA) and the primers 5=-GGGG ACAAGTTTGTACAAAAAAGCAGGCTAATGATAATAATAAGGAGA ACTC-3= and 5=-GGGGACCACTTTGTACAAGAAAGCTGGGTCAAC TGTTACGTGAGCTTGA-3=. The underlined sequences were attB sequences for the BP clonase reaction. The PCR product was cloned into the donor vector pDONR221 using the BP clonase, yielding pDONR221-sse M28 . The sse M28 gene in pDONR221 was transferred into pDCBB-RFA by the LR clonase, yielding pDCBB-sse M28 . The cloned sse M28 gene was confirmed by PCR and DNA sequencing. pDCBB-sse M28 or pDCBB (vector control) was introduced into MGAS6180 and its ⌬sse ⌬covS mutant via electroporation, as described previously (38) .
In trans expression of sse M28 in MGAS6180 and the ⌬sse ⌬covS mutant was evaluated by Western blotting with mouse anti-SsE M28 antisera. MGAS6180 or the ⌬sse ⌬covS mutant containing pDCBB-sse M28 or pDCBB (vector control) was grown in protein-reduced Todd-Hewitt broth supplemented with 0.2% yeast extract (THY) (PR-THY) in the presence of 10 g of chloramphenicol/ml to an OD 600 of 0.35, and the cultures were centrifuged to obtain supernatant. Proteins in 10 ml of supernatant were precipitated with 30 ml of cold ethanol, and the precipitates were pelleted by centrifugation and dissolved in 200 l of 1ϫ sodium dodecyl sulfate (SDS) loading buffer. PR-THY was prepared by passing THY through a membrane filter with a 10,000-molecular-weight cutoff. Western blotting was performed as described previously (33) . Proteins in 10 l of the obtained samples were resolved by SDS-PAGE and transferred to nitrocellulose membranes (BioTrace NT; Pall Corp.) with Towbin transfer buffer using a Trans-Blot SD semidry transfer cell (Bio-Rad) at 15 V for 45 To prepare anti-SsE M28 antisera, 2 female BALB/c mice (5 weeks old) obtained from Charles River Laboratories were immunized subcutaneously on day 1 and then boosted with 50 g of purified recombinant SsE M28 suspended in 50 l of aluminum hydroxide gel (Sigma) on day 14. Immune antiserum was collected 2 weeks after the boost.
For subcutaneous infection of mice, GAS without or with plasmid was grown to the mid-exponential phase in THY without and with 10 mg of chloramphenicol/liter, respectively. The bacteria were harvested by centrifugation and then first washed three times with and then resuspended in pyrogen-free Dulbecco phosphate-buffered saline (DPBS) in the desired doses. Groups of female CD1 mice (5 weeks old; Charles River Laboratory) were subcutaneously infected with 0.2 ml of GAS suspension in DPBS at OD 600 of 3.0, and inocula were determined by plating. Mice were sacrificed at 24 h after inoculation to collect skin for measurement of the infected lesion size and neutrophil infiltration. The 24-h time point was chosen based on pilot test results that neutrophil levels and skin lesion sizes did not change much after 24 h after GAS inoculation.
Quantification of neutrophil infiltration. The skin around infection site was peeled off, and infection area in the skin was recognized by the boundary of inflammation in its picture and measured by using the area measurement tool of the Adobe Acrobat 9 software program (Adobe Systems, Inc.). The skin containing the infection area was excised for neutrophil measurement. Numbers of recruited neutrophils in the infected skin samples were determined by the myeloperoxidase assay, as described previously (8, 40) . The skin samples were grinded in 0.5% hexadecyltrimethylammonium bromide in 50 mM potassium and sonicated on ice for 15 s to extract myeloperoxidase. The samples were frozen and thawed for three times, sonicated, and centrifuged at 16,000 ϫ g for 5 min. The myeloperoxidase activity in the supernatant obtained was measured in 0.2 ml of 50 mM phosphate buffer (pH 6.0), containing the supernatant, 0.167 mg of o-dianisidine dihydrochloride/ml, and 0.001% hydrogen peroxide. The change in absorbance at 460 nm (⌬A 460 ) was recorded with time with a SPECTRA Max 384 Plus spectrophotometer (Molecular Devices, Sunnyvale, CA). The myeloperoxidase activity, ⌬A 460 /min, was converted into the number of neutrophils using a standard curve of myeloperoxidase activities using known numbers of murine neutrophils.
Statistical analyses. Statistical analyses of the data of the animal experiments were performed using the GraphPad Prism software with the two-tailed, unpaired Student t test with Welch's correction and the analysis of variance Tukey's multiple-comparison test.
RESULTS
PAF-AH activity of SsE
M28 . Recombinant SsE M28 was purified to apparent homogeneity (Fig. 1A) . Whether SsE M28 hydrolyzes PAF into lyso-PAF was determined by thin-layer chromatography (TLC) analysis. PAF C16 (0.29 mM) was incubated with 7 M SsE M28 for 20 min, and the reaction was stopped by the addition of 50% acetonitrile. SsE M28 -treated PAF migrated the same distance in TLC as lyso-PAF, indicating that PAF was converted into lyso-PAF in the treatment with SsE M28 (Fig. 1B) . To confirm that the PAF hydrolysis was due to the enzymatic activity of SsE M28 , we performed a control experiment using PAF without addition of SsE M28 . PAF from this sham treatment retained the migration rate of PAF in TCL (Fig. 1B) , indicating no hydrolysis of PAF in the absence of SsE M28 . These results indicate that SsE M28 can hydrolyze the acetyl ester bond in PAF and thus has the PAF-AH activity (Fig. 1C) .
Enzymatic parameters of SsE M28 , SsE M1 , and hpPAF-AH for PAF hydrolysis. The Michaelis constant (K m ) is associated with the affinity of an enzyme for substrate, and the catalytic rate constant (k cat ) is a measure of the catalytic production of product at saturated substrate concentrations for the enzyme. These parameters provide information on whether an enzyme efficiently targets a substrate. To determine whether SsE M28 and SsE M1 target PAF, we compared the K m and k cat of SsE M28 and SsE M1 in PAF hydrolysis with an authentic PAF-AH, hpPAF-AH. In the colorimetric assay, PAF-AH catalyzes the hydrolysis of the acetyl thioester bond of 2-thio-PAF, a homologue of PAF, yielding a free thiol, which reacts with DTNB to form 2-nitro-5-thiobenzoate with an absorbance peak at 414 nm (A 414 ). The time courses of ⌬A 414 in Fig. 2A show that the hydrolysis of 2-thio-PAF was very fast even when SsE M28 concentration was at 1.5 nM. The apparent K m of the reaction was small, and low PAF concentrations had to be used to obtain the enzymatic parameters. The ⌬A 414 time course in the first 36 s of the reactions (Fig. 2B ) was used to calculate initial reaction rates at different 2-thio-PAF concentrations. Because significant portions of 2-thio-PAF had been hydrolyzed at time zero when the measurement started, 2-thio-PAF concentrations at time zero was adjusted by subtracting the hydrolyzed portion, as described previously (8) . The relationship of the initial rates versus the adjusted [2-thio-PAF] fits the Michaelis-Menten equation (Fig. 2C ). The observed rates as a function of [2-thio-PAF] also fit the Michaelis-Menten equation in the SsE M1 -and human pPAF-AH-catalyzed reactions (Fig. 2C) (Fig. 3A) . M1 proteins were apparently pure, and the purity of hpPAF-AH was Ͼ90% (Fig.  1A) . Thus, these K m and k cat values of the proteins in catalyzing the hydrolysis of 2-thio-PAF and PAF indicate that SsE M28 and SsE
M1
have high affinities for PAF and are more potent PAF-AH than hpPAF-AH. SsE M28 appears to be the only PAF-AH produced by MGAS6180. PAF-AHs are members of the phospholipase A 2 family. MGAS6180 also produces another phospholipase A 2 protein, SlaA (41, 42) . To determine whether SlaA also has the PAF-AH activity, we tested hydrolysis of 2-thio-PAF by SlaA. The activity was barely detectable when 3.1 M SlaA was used, and the specific activity of SlaA for 2-thio-PAF hydrolysis was just 0.003 mol/ min/mg for Sla, which was 4 orders of magnitude lower than that of SsE M1 . Thus, SlaA does not have the PAF-AH activity. Consistent with this conclusion, deletion of the sse gene in MGAS6180 abolished the PAF-AH activity in the culture supernatant of MGAS6180 (see Fig. 6B ). It appears that SsE M28 is the only PAF-AH produced by MGAS6180. , and hpPAF-AH used in the assay were 37.4, 14.5, and 215.5 pM, respectively. The presented data are adjusted from the observed data for a concentration of 215.5 pM for all of the proteins for comparison. Data are from a representative duplicate experiment. strate specificity of the SsE proteins by testing various esters using potentiometric titration with a pH-stat in which NaOH was automatically pumped in to neutralize released acid and keep pH of the reaction solution constant. SsE M1 -catalyzed hydrolysis of ethyl acetate is used to show a typical titration curve. After SsE M1 was mixed with 50 mM ethyl acetate, the accumulative NaOH volume pumped increased linearly with time ( Fig. 5A) , giving a slope of 0.073 ml of 0.02 M NaOH min Ϫ1 , which was used to calculate the hydrolysis rate. The hydrolysis rate depended hyperbolically on the substrate concentration and fit the Michaelis-Menten equation (Fig. 5B) . No hydrolysis was observed in a control reaction without SsE M1 (Fig. 5A ). We tested a series of triglycerides, including triacetylglycerol, tripropionylglycerol, tributyroylglycerol, and trioctanoylglycerol. One feature in this test is that both SsE M1 and SsE M28 , like hpPAF-AH, had the highest activity against tryacetylglycerol (Table 2) . Because the solubility of these triglycerides in water decreases with the increase in the chain length of the acyl group, it is possible that the activity-decreasing trend with the acyl chain length-increasing triglycerides is determined by their solubility. We examined this possibility by testing the hydrolysis of vinyl acetate, vinyl propionate, and vinyl butyrate. These compounds all have good solubility, and their solubility should not be a factor. The specific activity of both SsE M1 and SsE M28 still dramatically decreased with the increase in the acyl chain length of this series of esters, supporting the notion that both SsE proteins have genuine, optimal activities against acetyl esters.
S. equi
We then tested whether the alcohol moiety of acetyl esters contributes to the substrate specificity of both SsE proteins. Both SsE M1 and SsE M28 had lower specificity activity against ethyl acetate than triacetylglycerol and had no activity against acetylcholine. Thus, the alcohol moiety of acetyl esters plays a role in the substrate activity. It is noticeable that SsE M28 had lower activities against triglycerides and other nonlipophilic esters than SsE M1 ( Table 2) .
Effects of sse M28 deletion on neutrophil recruitment and skin invasion. As an important lipid mediator, PAF can activate platelets and neutrophils and is involved in inflammation. Since SsE M28 has the PAF-AH activity, we hypothesize that SsE M28 can detrimentally affect neutrophil responses to GAS infection, contributing to GAS pathogenesis. The effect of SsE M1 on neutrophil recruitment and skin invasion is more profound in M1 strains that carry a null covS mutation than strains carrying wild-type CovS because SsE M1 is expressed at higher levels in isolates with null covS mutations (8, 17, 33) . Thus, we deleted the sse gene in MGAS6180 and the covS gene in both MGAS6180 and its ⌬sse mutant for examining the effect of sse M28 deletion on infection outcomes. As expected, deletion of covS in MGASS6180 did not change the levels of the emm transcript for the M protein but enhanced the transcript levels of hasA and sse (Fig. 6A) , which are the known targets of CovRS. The sse and covS deletions in MGAS6180 abolished and increased the PAF-AH activity in the culture supernatant, respectively (Fig. 6B) . It should be noted that the covS deletion-caused 5.6-fold change in the levels of sse transcript in MGAS6180 (Fig. 6A) was smaller than the covS deletioncaused 10-fold increase in the levels of sse transcript in MGAS2221 (33). This difference could be due to the following difference in sse expression between the two wild-type strains: the PAF-AH activity of SsE was detected in the culture supernatant of MGAS6180 but not MGAS2221 (data not shown). An additional difference between MGAS6180 and MGAS2221 was that the SpeB activity was detected in the supernatant of overnight MGAS2221 culture but not MGAS6180 (data not shown). It appears that there is a difference between MGAS6180 and MGAS2221 in CovRS-mediated regulation of speB and sse. However, CovRS still negatively regulates sse in MGAS6180, and deletion of covS in MGAS6180 enhances SsE production.
The ⌬sse mutant caused smaller lesions (63.6 Ϯ 3.6 mm 2 ) than MGAS6180 (72.3 Ϯ 6.8 mm 2 ), but the difference was not significant (P ϭ 0.5476) (Fig. 6C ) in subcutaneous infection of CD1 mice, and the levels of neutrophils at the parent and ⌬sse mutant sites were similar (Fig. 6D) . However, deletion of sse in MGAS6180 significantly reduces skin invasion and enhances neutrophil recruitment under the background of a null covS mutation. Compared to MGAS6180, the deletion of covS in MGAS6180 increased lesion sizes by 3.1-fold (P Ͻ 0.0001) (Fig. 6C ) and reduced neutrophil recruitment by 68% (P Ͻ 0.05) (Fig. 6D) . The covS deletion-caused increase in skin invasion and reduction in neutrophil recruitment were largely reversed by sse deletion. The ⌬sse ⌬covS mutation caused a lesion size of 88.4 Ϯ 8.8 mm 2 , which was 39% of that caused by the ⌬covS mutation (226.3 Ϯ 36.3 mm 2 ) (P Ͻ 0.0001) (Fig. 6C) , and the levels of neutrophils at ⌬sse ⌬covS sites [(4.9 Ϯ 1.0) ϫ 10 5 neutrophils/mm 2 ] were 3.3 times that at ⌬covS sites [(1.5 Ϯ 0.4) ϫ 10 5 neutrophils/mm 2 ] (P Ͻ 0.05) (Fig. 6D) . Thus, SsE M28 significantly contributes to skin invasion and inhibition of neutrophil recruitments under the nonfunctioning covS background.
To further confirm the contribution of the sse deletion to the 
FIG 6 Effect of sse
M28 deletion on GAS skin invasion and inhibition of neutrophil recruitment in subcutaneous infection of mice. (A) Relative levels of emm, hasA, and sse transcripts in MGAS6180 and its ⌬sse, ⌬covS, and ⌬sse ⌬covS mutants at the mid-log growth phase. (B) PAF-AH activity in a 100-l culture supernatant of MGAS6180 and its mutants at the mid-log growth phase, which was monitored as the change in A 414 in the 2-thio-PAF hydrolysis assay. (C and D) Lesion sizes (C) and neutrophil infiltration at lesion sites (D) in mice subcutaneously infected with 7.9 ϫ 10 8 CFU of MGAS6180, 7.2 ϫ 10 8 CFU of ⌬sse mutant, 9.0 ϫ 10 8 CFU of ⌬covS mutant, or 9.5 ϫ 10 8 CFU of ⌬sse ⌬covS mutant. Statistical analysis: *, **, or ***, significant; ns, not significant. inhibition of neutrophil recruitment and skin invasion, we complemented the sse deletion by in trans expression of SsE M28 in ⌬sse ⌬covS mutants. Western blotting detected a strong SsE M28 band in the culture supernatant of ⌬sse ⌬covS mutants carrying pDCBBsse M28 , but no SsE M28 band was detected in the culture supernatant of ⌬sse ⌬covS mutants carrying pDCBB (vector control), whereas similar levels of Spy0019, a secreted protein, were detected in the two samples (Fig. 7A) . The culture supernatant of ⌬sse ⌬covS mutant/pDCBB-sse M28 had high PAF-AH activity, whereas no PAF-AH activity was detected in the supernatant of ⌬sse ⌬covS strain/pDCBB culture (Fig. 7B) , confirming the Western blotting results. The lesion size in ⌬sse ⌬covS strain/pDCBB-sse M28 infection was 105.6 Ϯ 7.0 mm 2 , which was nearly as twice as that in ⌬sse ⌬covS strain/pDCBB infection (55.8 Ϯ 4.7 mm 2 ) (P Ͻ 0.0001) (Fig. 7C) . The levels of neutrophils at the ⌬sse ⌬covS strain/ pDCBB-sse M28 site [(3.4 Ϯ 0.5) ϫ 10 5 neutrophils/mm 2 ] was less than half of that at the ⌬sse ⌬covS MGAS6180 strain/pDCBB site [(7.7 Ϯ 1.5) ϫ 10 5 neutrophils/mm 2 ] (P ϭ 0.0011) (Fig. 7D) . Thus, SsE M28 has a similar function to reduce neutrophil infiltration and increase skin invasion and is subject to the similar CovRS regulation as SsE M1 . Effect of in trans expression of sse M28 in MGAS6180 on neutrophil recruitment and skin invasion. The sse M28 deletion results described above raise a question on whether SsE M28 exerts an effect only when GAS lacks the functioning CovRS. To examine this issue, we examined the effect of in trans expression of SsE M28 in MGAS6180 on infection outcomes. A weak SsE M28 band could be detected if a more concentrated MGAS6180/pDCBB sample was analyzed (data not shown). Western blotting and PAF-AH activity analyses indicate the achievement of SsE M28 overexpression in MGAS6180 using pDCBB-sse M28 ( Fig. 7A and B ). MGAS6180/pDCBB-sse M28 caused greater lesions (53.0 Ϯ 3.3 mm 2 ) than MGAS6180/pDCBB (vector control) (37.1 Ϯ 2.1 mm 2 ) (P ϭ 0.0029) (Fig. 7C) . The in trans expression of SsE M28 in MGAS6180 reduced neutrophil infiltration [(7.4 Ϯ 1.0) ϫ 10 5 neutrophils/mm 2 ] by 50% compared to the control [(1.5 Ϯ 0.1) ϫ 10 6 neutrophils/mm 2 ] (P ϭ 0.0015) (Fig. 7D) . Thus, SsE M28 can detrimentally affect neutrophil infiltration and enhance skin evasion under the functional CovRS background when it is expressed at sufficient levels.
DISCUSSION
We report the findings on SsE, a secreted protein that is a protective antigen and virulence factor and functions in part by hydrolyzing PAF. First, SsE M28 , which represents the second group of SsE variants, also has potent PAF-AH activity despite of 37% sequence variation from SsE M1 , which represents the first group of SsE variants. Second, both SsE M1 and SsE M28 show higher activity against PAF than hpPAF-AH but have different activities against lipophilic esters and other esters, indicating that SsE M28 is a more specific PAF-AH and that SsE M1 is more like hpPAF-AH with a broader substrate specificity. Third, SsE M28 contributes to GAS invasion of the skin and inhibition of neutrophil recruitment. These findings provide new information on the function and functional mechanism of SsE.
Our M1 and SsE M28 suggests that both of the proteins function through the PAF-AH activity.
Inhibition of neutrophil recruitment is one of the mechanisms for GAS to invade neutrophil responses. It has been known that GAS produces the peptidases ScpA and SpyCEP to degrade the C5a peptide and IL-8/CXC chemokines, respectively (3) (4) (5) (6) (7) . SsE is a recently found novel factor that contributes to GAS inhibition of neutrophil recruitment (8) . All of these three factors are regulated by the two-component regulatory system CovRS (33, 43, 44) . Hypervirulent GAS can almost completely inhibit neutrophil infiltration (4, 8, (45) (46) (47) and have enhanced expression of the spyCEP and sse genes (33, 43, 44) . Null deletion and mutations of the covS gene cause the severe inhibition of neutrophil infiltration, and SsE is the most critical factor among SsE, ScpA, and SpyCEP for the covS deletion/mutation-mediated enhancement in innate immune evasion and virulence (17) . The findings on SsE M28 suggest that the function of SsE in innate immune evasion by targeting PAF is conserved even the sequence of SsE M28 is extensively diverged from that of SsE M1 . GAS possesses either SsE M1 -type or SsE M28 -type SsE protein depending on the serotype. Apparently, GAS uses SsE to evade innate immune response regardless of the serotypes.
Like SsE M1 , SsE M28 also significantly contributes to skin invasion, which may be the consequence of the SsE-mediated reduction in the neutrophil responses or attributable to an unknown mechanism. In addition, both SsE M28 and SsE M1 (10, 19, 35) have a more substantial effect on neutrophil infiltration and skin infection for GAS strains with nonfunctional covS compared to strains with the wild-type covS gene. This is apparently due to higher expression levels of sse in null covS mutants of MGAS6180 and M1T1 GAS isolates.
The preservation of the PAF-AH activity of SsE M1 , SsE M28 , and their S. equi homologue SeE suggests that the function and functional mechanism of SsE is not limited to GAS. SsE M1 shares 33 to 94% sequence identity with a putative secreted protein in a number of bacterial pathogens, which notably include Streptococcus dysgalactiae subsp. equisimili (94% sequence identity), Streptococcus dysgalactiae subsp. dysgalactiae (86%), Streptococcus canis (82%), Streptococcus urinalis (64%), Streptococcus equi subsp. zooepidemicus (62%), Streptococcus equi subsp. equi (62%), Streptococcus iniae (61%), Streptobacillus moniliformis (41%), Clostridium kluyveri (38%), Lactobacillus oris (36%), Lactobacillus antri (36%), Actinomyces coleocanis (36%), and Staphylococcus aureus (33%). Sequence alignment of selected SsE homologues is presented in Fig. 8 . Notably, Streptococcus pneumoniae does not have an SsE homologue; however, this pathogen produces the protein Pce that can hydrolyze the phosphocholine group of PAF (48) . It is possible that a redundant SsE homologue targeting PAF is not needed because of the production of Pce.
